Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.

Journal: American Journal Of Hematology
Published:
Abstract

Chromosomal abnormalities in Ph-negative metaphases from patients with chronic myeloid leukemia (CML) treated with imatinib have been described in some cases. Trisomy 8 is the most frequent, but monosomy 7 has also been described. However, the association of these chromosomal alterations with myelodysplasia has been scarcely reported. We report the appearance of monosomy 7 in Ph-negative cells, associated with severe dysplasia, in two patients with CML treated with imatinib, with a different outcome: one with a transient evolution and the other evolving to acute myeloid leukemia.

Authors
José-tomás Navarro, Evarist Feliu, Javier Grau, Blanca Espinet, Dolors Colomer, Josep-maria Ribera, Albert Oriol, Isabel Granada, Jordi Juncà, Fuensanta Millá